This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Mayo Foundation for Medical Education and Research, Osaka University. Active years: 2016.
Company Filing History:
1 out of 1,808 
1 out of 1,041 
Years Active: 2016
Title: Takehiko Yoshimitsu: Innovator in Cancer Treatment
Introduction
Takehiko Yoshimitsu is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on addressing critical health challenges, particularly in treating brain cancer.
Latest Patents
Yoshimitsu holds a patent for "Substituted imidazo[4',5':4,5]cyclopenta[1,2-e]pyrrolo[1,2-a]pyrazines and oxazolo[4',5':4,5]cyclopenta[1,2-e]pyrrolo[1,2-a]pyrazines for treating brain cancer." This patent relates to compounds and compositions that are useful for treating various cancers, including those affecting the brain and nervous system. The compounds include a compound of Formula I or a pharmaceutically acceptable salt thereof, which demonstrates potential in cancer therapy.
Career Highlights
Throughout his career, Yoshimitsu has been associated with prestigious institutions such as Osaka University and the Mayo Foundation for Medical Education and Research. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Yoshimitsu has collaborated with notable colleagues, including Han W Tun and Daisuke Shigeoka. These partnerships have enriched his research endeavors and fostered innovation in cancer treatment.
Conclusion
Takehiko Yoshimitsu's contributions to cancer treatment through his patented innovations highlight his dedication to improving healthcare outcomes. His work continues to inspire advancements in the field of oncology.